Literature DB >> 1749941

Variables associated with decreased survival in systemic lupus erythematosus.

M J Seleznick1, J F Fries.   

Abstract

Fifty-one deaths occurred among 310 patients with systemic lupus erythematosus (SLE) observed for 1,234 patient-years. Twenty-one of 97 entry variables at first clinic visit were associated with an increased risk of mortality. When corrected for multiple comparisons, the only risk factor that retained statistical significance was systolic blood pressure. Each millimeter unit increase in systolic blood pressure corresponded to a 2% increase in mortality risk. Stepwise covariance and recursive partitioning analyses tended to identify nonspecific prognostic variables, rather than the classic serological and diagnostic features of SLE. These data suggest that hypertension is a more significant risk factor for mortality in SLE than the more specific measures of disease severity.

Entities:  

Mesh:

Year:  1991        PMID: 1749941     DOI: 10.1016/0049-0172(91)90040-7

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN: 0049-0172            Impact factor:   5.532


  8 in total

Review 1.  Prognosis in systemic lupus erythematosus.

Authors:  J M Esdaile
Journal:  Springer Semin Immunopathol       Date:  1994

2.  Definition of risk factors for death, end stage renal disease, and thromboembolic events in a monocentric cohort of 338 patients with systemic lupus erythematosus.

Authors:  K Manger; B Manger; R Repp; M Geisselbrecht; A Geiger; A Pfahlberg; T Harrer; J R Kalden
Journal:  Ann Rheum Dis       Date:  2002-12       Impact factor: 19.103

3.  Critical illness in systemic lupus erythematosus and the antiphospholipid syndrome.

Authors:  F M K Williams; S Chinn; G R V Hughes; R M Leach
Journal:  Ann Rheum Dis       Date:  2002-05       Impact factor: 19.103

4.  Development and Verify of Survival Analysis Models for Chinese Patients With Systemic Lupus Erythematosus.

Authors:  Linyu Geng; Wenqiang Qu; Jun Liang; Wei Kong; Xue Xu; Wenyou Pan; Lin Liu; Min Wu; Fuwan Ding; Huaixia Hu; Xiang Ding; Hua Wei; Yaohong Zou; Xian Qian; Meimei Wang; Jian Wu; Juan Tao; Jun Tan; Zhanyun Da; Miaojia Zhang; Jing Li; Huayong Zhang; Xuebing Feng; Jiaqi Chen; Lingyun Sun
Journal:  Front Immunol       Date:  2022-06-24       Impact factor: 8.786

5.  Outcome of lupus nephritis in Iranian children: prognostic significance of certain features.

Authors:  Neamatollah Ataei; Manijeh Haydarpour; Abbas Madani; Seyed Taher Esfahani; Niloufar Hajizadeh; Mohammad Hasan Moradinejad; Taghi Gholmohammadi; Shahriar Arbabi; Marzieh Haddadi
Journal:  Pediatr Nephrol       Date:  2008-02-13       Impact factor: 3.714

Review 6.  The epidemiology of systemic lupus erythematosus.

Authors:  Sònia Jiménez; Ricard Cervera; Josep Font; Miguel Ingelmo
Journal:  Clin Rev Allergy Immunol       Date:  2003-08       Impact factor: 8.667

7.  Incidence and prevalence of lupus in Buenos Aires, Argentina: a 11-year health management organisation-based study.

Authors:  M Scolnik; J Marin; S M Valeiras; M F Marchese; A S Talani; N L Avellaneda; A Etchepare; P Etchepare; M S Plou; E R Soriano
Journal:  Lupus Sci Med       Date:  2014-06-05

8.  Risk factors for cardiovascular mortality in patients with systemic lupus erythematosus, a prospective cohort study.

Authors:  Johanna T Gustafsson; Julia F Simard; Iva Gunnarsson; Kerstin Elvin; Ingrid E Lundberg; Lars-Olof Hansson; Anders Larsson; Elisabet Svenungsson
Journal:  Arthritis Res Ther       Date:  2012       Impact factor: 5.156

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.